Dr. Ana Mingorance is a specialist in genetic epilepsy syndromes and an independent consultant in CNS and orphan drug development. Ana has close relationships with patient groups, acting as a scientist-in-residence, scientific advisor, and patient advocate. She is the author of eBook #ImpatientRevolution, a guide for impatient patient organisations.
She is the former Scientific Director of the Dravet Syndrome Foundation Spain, and is currently Scientific Advisor to the Dravet Syndrome European Federation. In this space, Ana built and managed a portfolio of research collaborations ranging from diagnostics to clinical research, hosted two European congresses on rare epilepsies, generated the first open-access mouse model for Dravet syndrome, and is a regular speaker at rare disease conferences.
Before starting her own business, Ana was a laboratory head and discovery project leader at the global biopharmaceutical company UCB Pharma in Belgium. She received her PhD in Neuroscience from the University of Barcelona in Spain and completed an EMBO Postdoctoral Fellowship at the University of British Columbia in Canada.